Ann Cunningham
Vermogen: - $ op 31-05-2026
Vermogen: - $ op 31-05-2026
Ann Cunningham is the founder of I3 Strategy Partners LLC.
Ms. Cunningham is currently an Independent Director at Vistagen Therapeutics, Inc. since 2022 and an Independent Non-Executive Director at Alterity Therapeutics Ltd. starting in 2026.
Formerly, Ms. Cunningham was Senior Director-Global Brand at Eli Lilly & Co. from 1999 to 2013, Senior Marketing Director at Otsuka America Pharmaceutical, Inc. from 2013 to 2015, and Vice President-Neurodegenerative Disease at Teva Pharmaceutical Industries Ltd. from 2015 to 2018.
Ms. Cunningham completed undergraduate studies at Yale University and earned an MBA from Stephen M.
Ross School of Business.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 09-09-2025 | 0 ( -.--% ) | - $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| VISTAGEN THERAPEUTICS, INC. | Directeur/Bestuurslid | 10-01-2019 |
| ALTERITY THERAPEUTICS LIMITED | Directeur/Bestuurslid | 17-04-2026 |
| Bedrijven | Functie | Einde |
|---|---|---|
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Corporate Officer/Principal | 01-01-2018 |
Otsuka America Pharmaceutical, Inc.
Otsuka America Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceutical products | Corporate Officer/Principal | 01-01-2015 |
| ELI LILLY AND COMPANY | Corporate Officer/Principal | 01-01-2013 |
I3 Strategy Partners LLC | Oprichter | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 8 |
|---|---|
Eli Lilly & Co.
Eli Lilly & Co. Pharmaceuticals: MajorHealth Technology Manufactures, wholesales and markets pharmaceutical products | Health Technology |
Teva Pharmaceutical Industries Ltd.
Teva Pharmaceutical Industries Ltd. Pharmaceuticals: GenericHealth Technology Manufactures and markets generic and proprietary branded pharmaceuticals and active pharmaceutical ingredients | Health Technology |
Alterity Therapeutics Ltd.
Alterity Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Develops therapeutic drugs | Health Technology |
Yale University
Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Otsuka America Pharmaceutical, Inc.
Otsuka America Pharmaceutical, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and supplies pharmaceutical products | Health Technology |
Stephen M. Ross School of Business
Stephen M. Ross School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
VistaGen Therapeutics, Inc.
VistaGen Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company that develops central nervous system therapies | Health Technology |
I3 Strategy Partners LLC |
Kies jouw editie
Alle financiële informatie op nationaal niveau